Find
Nov 25, 2014

Eurex

Reckitt Benckiser Group PLC: Demerger of Indivior PLC

On 17 November 2014, Reckitt Benckiser Group PLC published further information about the demerger of its pharmaceuticals business announced on 28 July 2014. The demerger will be decided in a shareholder meeting on 11 December 2014. Shareholders of Reckitt Benckiser Group PLC shall receive one Indivior PLC share for each existing Reckitt Benckiser Group PLC share they hold. The demerger is scheduled to take effect on 23 December 2014.

For further information regarding this transaction, please refer to the company’s website www.rb.com.

The circular contains a description of the adjustment procedure for the Eurex option series (RBE) and the Eurex Single Stock Futures contract (RBFF) on shares of Reckitt Benckiser Group PLC.

Market Status

XEUR

The market status window is an indication regarding the current technical availability of the trading system. It indicates whether news board messages regarding current technical issues of the trading system have been published or will be published shortly.

Please find further information about incident handling in the Emergency Playbook published on the Eurex webpage under Support --> Emergencies and safeguards. Detailed information about incident communication, market re-opening procedures and best practices for order and trade reconciliation can be found in the chapters 4.2, 4.3 and 4.5, respectively. Concrete information for the respective incident will be published during the incident via newsboard message. 

We strongly recommend not to take any decisions based on the indications in the market status window but to always check the production news board for comprehensive information on an incident.

An instant update of the Market Status requires an enabled up-to date Java™ version within the browser.